Ryvu Therapeutics S.A. (WSE:RVU)
Poland · Delayed Price · Currency is PLN 17.08
+0.10 (0.59%)
Sep 4, 2026, 5:00 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 394.89 million as of September 4, 2026. Its market cap has decreased by -38.56% in one year.
Market Cap
394.89M
Enterprise Value
407.82M
Revenue
88.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.08
ChartMarket Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 394.89M, an increase of 598.88%. That is a compound annual growth rate of 13.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 394.89M | -36.97% |
| Dec 30, 2025 | 626.56M | -29.61% |
| Dec 30, 2024 | 890.13M | -33.04% |
| Dec 29, 2023 | 1.33B | 16.75% |
| Dec 30, 2022 | 1.14B | 1.70% |
| Dec 30, 2021 | 1.12B | 23.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 497.56M |
| Captor Therapeutics Spolka Akcyjna | 451.09M |
| Bioceltix | 439.26M |
| BIOTON | 323.71M |
| Synthaverse | 226.55M |
| Poltreg | 136.67M |
| Molecure | 131.86M |
| Mabion | 124.13M |